Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CYCC Cyclacel Pharmaceuticals

已收盘 11-21 16:00:00 EST

0.3473

-0.0240

-6.46%

盘后0.3401

-0.0072-2.07%

19:15 EST

最高0.3770	最低0.3241	成交量36.46万
今开0.3607	昨收0.3713	日振幅14.25%
总市值218.35万	流通市值210.81万	总股本628.72万
成交额12.58万	换手率6.01%	流通股本606.99万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CYCC","market":"US","secType":"STK","nameCN":"Cyclacel Pharmaceuticals","latestPrice":0.3473,"timestamp":1732222800000,"preClose":0.3713,"halted":0,"volume":364595,"hourTrading":{"tag":"盘后","latestPrice":0.3401,"preClose":0.3473,"latestTime":"19:15 EST","volume":2036,"amount":706.3843,"timestamp":1732234501215},"delay":0,"floatShares":6069900,"shares":6287200,"eps":-7.467854,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.024,"latestTime":"11-21 16:00:00 EST","open":0.3607,"high":0.377,"low":0.3241,"amount":125780.8415248,"amplitude":0.142472,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-7.467854,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":1079413200000,"adjPreClose":0.3713,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.3585,"preClose":0.3752,"latestTime":"09:28 EST","volume":7349,"amount":2601.77859585,"timestamp":1732199287277},"postHourTrading":{"tag":"盘后","latestPrice":0.3401,"preClose":0.3473,"latestTime":"19:15 EST","volume":2036,"amount":706.3843,"timestamp":1732234501215},"volumeRatio":0.746553,"impliedVol":6.1603,"impliedVolPercentile":0.9565},"requestUrl":"/m/hq/s/CYCC","defaultTab":"news","newsList":[{"id":"2485649793","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘大幅下挫8.43%报0.340美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485649793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485649793?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:32","pubTimestamp":1732199566,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时32分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅跳水8.43%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Conduit Pharmaceuticals Inc.、Cidara Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Biodexa Pharmaceuticals Plc、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为215.35%、56.18%、42.69%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为66.75%、38.33%、14.55%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223246abd4e6cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223246abd4e6cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","CYCCP","BK4139"],"gpt_icon":0},{"id":"2485499891","title":"Cyclacel Pharmaceuticals, Inc.2024财年第三财季实现净利润-1.96百万美元，同比增加67.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485499891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485499891?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:00","pubTimestamp":1732118445,"startTime":"0","endTime":"0","summary":"11月21日，Cyclacel Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.96百万美元，同比增加67.50%；其中营业收入为10000.00美元，同比减少37.50%，每股基本收益为-0.91美元。从资产负债表来看，Cyclacel Pharmaceuticals, Inc.总负债6.35百万美元，其中短期债务0.00美元，资产负债比为0.85，流动比率为0.78。机构评级：截至2024年11月21日，当前有1家机构对Cyclacel Pharmaceuticals, Inc.目标价做出预测，其中目标均价为1.00美元，其中最低目标价为1.00美元，最高目标价为1.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000055a248ed91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121000055a248ed91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC"],"gpt_icon":0},{"id":"2484928438","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484928438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484928438?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:35","pubTimestamp":1732026933,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时35分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.89%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Exicure, Inc.涨幅较大，Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃，换手率分别为643.31%、80.62%、66.02%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tff Pharmaceuticals, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为52.14%、32.55%、28.79%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223533a245f1af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223533a245f1af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2484295985","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 急速下跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484295985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484295985?lang=zh_cn&edition=full","pubTime":"2024-11-19 04:05","pubTimestamp":1731960334,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日04时05分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.61%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，冠科美博、Hcw Biologics Inc.、Tharimmune, Inc.较为活跃，换手率分别为1476.02%、1309.96%、579.55%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为563.48%、221.58%、193.44%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119040534abcd36fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119040534abcd36fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2483370120","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 快速跳水5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483370120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483370120?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:40","pubTimestamp":1731681623,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时40分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.52%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.89%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115224023abc4ec7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115224023abc4ec7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2483280436","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大跌11.11%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483280436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483280436?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594703,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下跌11.11%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Pulmatrix, Inc.涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1441.85%、19.87%、11.32%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc.，振幅分别为25.00%、19.43%、15.53%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422314395be2c67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422314395be2c67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2483819458","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大涨8.54%报0.445美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483819458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483819458?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:30","pubTimestamp":1731508240,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时30分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅拉升8.54%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Kairos Pharma, Ltd.、Mersana Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为323.26%、168.18%、84.01%，振幅较大的相关个股有Entero Therapeutics Inc.、Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为8.29%、7.12%、6.81%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223040a2345365&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223040a2345365&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2482848540","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.46%报0.420美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482848540","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482848540?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:14","pubTimestamp":1731424448,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时14分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下跌6.46%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Cero Therapeutics Holdings, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Cero Therapeutics Holdings, Inc.、Geovax Labs, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为224.07%、161.38%、125.82%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为65.13%、49.39%、34.88%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112231408a230d34b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112231408a230d34b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2481833864","title":"Cyclacel Pharmaceuticals Inc 预计每股亏损56美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481833864","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481833864?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:45","pubTimestamp":1731080758,"startTime":"0","endTime":"0","summary":"Cyclacel Pharmaceuticals Inc 预计每股亏损56美分 - 财报前瞻Cyclacel Pharmaceuticals Inc CYCC.OQ CYCC.O预计将在11月11日公布截至2024年9月30日的业绩报告时显示季度收入下降(预计) 根据LSEG的数据，2位分析师的平均预期显示，这家总部位于新泽西州伯克利高地的公司的营收预计将从一年前的1.6万美元下降68.7%至5,000美元。LSEG 分析师对 Cyclacel Pharmaceuticals Inc 的平均预期是每股亏损 56 美分。华尔街对 Cyclacel Pharmaceuticals Inc 的 12 个月目标价中位数为 6.00 美元，高于上一交易日 0.43 美元的收盘价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF1Q8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCC"],"gpt_icon":0},{"id":"2481906102","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481906102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481906102?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:52","pubTimestamp":1731077543,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时52分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速跳水6.04%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为493.84%、44.33%、34.57%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Lipella Pharmaceuticals Inc.，振幅分别为86.00%、31.72%、29.95%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108225223abae495d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108225223abae495d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0},{"id":"2481398427","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 快速下跌5.65%报0.417美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481398427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481398427?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:43","pubTimestamp":1730907821,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时43分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.65%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为2210.77%、234.92%、98.86%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为73.16%、56.37%、32.38%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110623434298e40efa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110623434298e40efa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2481688672","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.92%报0.475美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481688672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481688672?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:41","pubTimestamp":1730817705,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时41分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.92%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105224145971a470a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105224145971a470a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2481538792","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481538792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481538792?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:48","pubTimestamp":1730735284,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时48分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.85%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为269.43%、264.63%、68.63%，振幅较大的相关个股有In8Bio, Inc.、Kazia Therapeutics Limited、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为45.39%、39.13%、31.90%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104234805971a4345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104234805971a4345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2480871038","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.82%报0.611美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480871038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480871038?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:44","pubTimestamp":1730472289,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时44分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.82%。截至发稿，该股报0.611美元/股，成交量7.2756万股，换手率3.38%，振幅2.53%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122444998e4008f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122444998e4008f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2479153033","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 大幅下挫5.25%报0.623美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479153033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479153033?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:51","pubTimestamp":1730382689,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时51分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.25%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.30%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 、Aerovate Therapeutics, Inc.涨幅较大，Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为212.06%、203.38%、153.39%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为39.30%、28.17%、21.98%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215129a202322b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215129a202322b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2479042285","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌5.93%报0.659美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479042285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479042285?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:32","pubTimestamp":1730208737,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时32分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.93%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Lixte Biotechnology Holdings, Inc.涨幅较大，Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为520.11%、248.88%、129.28%，振幅较大的相关个股有Glycomimetics, Inc.、Entero Therapeutics Inc.、Sangamo Therapeutics, Inc.，振幅分别为22.06%、11.54%、10.29%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921321895bd81fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921321895bd81fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","CYCC","BK4139"],"gpt_icon":0},{"id":"2477631828","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘大幅跳水6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477631828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477631828?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:31","pubTimestamp":1729776688,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下跌6.19%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.、Chromocell Therapeutics Corporation涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为196.80%、93.79%、30.29%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Hepion Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.，振幅分别为20.04%、12.73%、10.71%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421312995bd4d4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421312995bd4d4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCC","BK4139","CYCCP"],"gpt_icon":0},{"id":"2477535624","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘急速上涨8.39%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477535624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477535624?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:32","pubTimestamp":1729690326,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时32分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅上涨8.39%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Dbv Technologies涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为894.04%、492.09%、272.08%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Tevogen Bio Holdings Inc.，振幅分别为33.89%、22.02%、18.01%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321320695bd42d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321320695bd42d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCCP","BK4139","CYCC"],"gpt_icon":0},{"id":"2477533090","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大涨11.36%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477533090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477533090?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:31","pubTimestamp":1729603892,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速上涨11.36%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Tc Biopharm  Plc涨幅较大，Genprex, Inc.、Tc Biopharm  Plc、Ensysce Biosciences, Inc.较为活跃，换手率分别为1842.91%、1132.74%、1078.97%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Ensysce Biosciences, Inc.、Genprex, Inc.，振幅分别为52.51%、43.69%、25.83%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221313295bb6c2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221313295bb6c2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCC","CYCCP"],"gpt_icon":0},{"id":"2477886303","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘快速上涨10.53%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477886303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477886303?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:31","pubTimestamp":1729517512,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速拉升10.53%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Gri Bio, Inc.、Biovie Inc.、Werewolf Therapeutics, Inc.涨幅较大，Gri Bio, Inc.、Genprex, Inc.、Biovie Inc.较为活跃，换手率分别为1817.33%、579.47%、319.28%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Gri Bio, Inc.、Biovie Inc.，振幅分别为35.04%、27.59%、22.55%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121315295b8ccd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121315295b8ccd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCCP","CYCC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cyclacel.com","stockEarnings":[{"period":"1week","weight":-0.1749},{"period":"1month","weight":-0.7187},{"period":"3month","weight":-0.6906},{"period":"6month","weight":-0.8189},{"period":"1year","weight":-0.9087},{"period":"ytd","weight":-0.8609}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cyclacel Pharmaceuticals, Inc.是一家于1996年成立且处于发展阶段的生物制药公司，致力于用于治疗人类癌症和其它重大疾病的新药和与机体有关的药品的开发和商业化。Cyclacel是细胞周期领域的开拓者，它敢于利用仅适合口服的新药来治疗患者。它的目标是在其一系列商业产品和新药筛选机制发展的基础上成为一家着重于血液学、肿瘤学研究的多元化生物医学公司。作为一家处于发展阶段的企业，该公司所有的努力都贡献于其研究和发展上，指导临床试验，开发和收购新的知识产权，提高资金储备和收益率及训练员工。它的目标是开发和商业化面向细胞周期控制各个阶段和用于治疗癌症及其他重大疾病的小分子药物，尤其是那些医疗缺口很大的领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.006177},{"month":2,"riseRate":0.444444,"avgChangeRate":0.08133},{"month":3,"riseRate":0.388889,"avgChangeRate":-0.059058},{"month":4,"riseRate":0.421053,"avgChangeRate":-0.01166},{"month":5,"riseRate":0.421053,"avgChangeRate":-0.011259},{"month":6,"riseRate":0.157895,"avgChangeRate":-0.101938},{"month":7,"riseRate":0.526316,"avgChangeRate":-0.038718},{"month":8,"riseRate":0.263158,"avgChangeRate":-0.093712},{"month":9,"riseRate":0.473684,"avgChangeRate":-0.008621},{"month":10,"riseRate":0.315789,"avgChangeRate":-0.007856},{"month":11,"riseRate":0.368421,"avgChangeRate":-0.034564},{"month":12,"riseRate":0.5,"avgChangeRate":-0.018954}],"exchange":"NASDAQ","name":"Cyclacel Pharmaceuticals","nameEN":"Cyclacel Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cyclacel Pharmaceuticals,CYCC,Cyclacel Pharmaceuticals股票,Cyclacel Pharmaceuticals股票老虎,Cyclacel Pharmaceuticals股票老虎国际,Cyclacel Pharmaceuticals行情,Cyclacel Pharmaceuticals股票行情,Cyclacel Pharmaceuticals股价,Cyclacel Pharmaceuticals股市,Cyclacel Pharmaceuticals股票价格,Cyclacel Pharmaceuticals股票交易,Cyclacel Pharmaceuticals股票购买,Cyclacel Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}